DOSAGE INDEX / SINGLE
Sermorelin
Research, reported schedules and supply planning.
Review sermorelin pediatric and adult studies, historical GEREF approvals, body-composition findings, safety observations and analogue differences.
Source: PeptideDosages.com. Independently written summaries of reported protocols, not validated treatment recommendations. Reviewed for transcription on September 21, 2026.
Research Protocol & Dosage
Source-reported examples · not treatment recommendations
- Amount
- 200–500 micrograms per day in the adult example
- Frequency
- Once daily
- Cycle / observation period
- 3–6 months
- Route / research model
- Subcutaneous
The source includes separate pediatric material; adult figures must not be applied to children.
Titration & progression
A dose range is not a titration schedule. No independently verified stepwise escalation has been established for this source-reported regimen.
Supply & Planning
Compare vial strengths here. A different vial size changes the available material, not the biological dose.
Diluent & formulation
Diluent compatibility is formulation-specific. A verified manufacturer instruction is still needed before bacteriostatic water or another diluent can be listed as suitable for this research material.
Vial comparison
No single complete schedule is resolved for this entry. Enter a documented total to compare strengths; the calculator does not select a regimen.
| Vial strength | Vials needed |
|---|---|
| 5 mg | Enter a total |
| 10 mg | Enter a total |
Enter a positive material total.
Material minimum only: round total material ÷ vial content up to a whole vial. Actual supply may be higher because of single-use packaging, discard dates, dead space or losses. No validated multi-use storage period is assumed.
Reported Research Results
Selected observations from the cited research. Each finding retains its study population, formulation and limitations.
- A multicenter, open-label study treated 110 previously untreated prepubertal children with GH deficiency for up to one year; 86 were eligible for efficacy analysis. Mean height velocity increased from 4.1 centimeters per year at baseline to 8.0 at six months and 7.2 at 12 months. [1]
- A separate study followed 11 healthy older men for six weeks. Nocturnal GH release increased, but IGF-I did not. Two of six strength measures and an abdominal endurance test improved. Weight, DEXA measures of muscle and fat, muscle histology and several metabolic measures did not change. [2]
- The pediatric study reported no adverse changes in the general biochemical or hormonal analyses and no change in fasting glucose. [1]
Sourcing & Vendor Information
No compound-specific affiliate destination is listed here yet. Browse the Vendors Index for the available supplier records and disclosed relationships.
Sources & Further Reading
Medical publications and supporting literature from the corresponding protocol bibliographies, combined across vial strengths. Supplier and commercial catalog references are excluded. Duplicate destinations appear once. Inclusion does not mean that a paper validates the reported dose, or that an ingredient study tests the finished blend.
Bibliography checked September 22, 2026: 30 entries mapped from 2 source pages. Medical and supporting references are retained below; supplier entries are excluded.
- Original GEREF International Study Group report
- Original Vittone study
- PubMedFurther reading · Listed in reference bibliography.
- RxListFurther reading · Listed in reference bibliography.
- Mayo ClinicGeneral guidance · Listed in reference bibliography.
- Johns Hopkins Arthritis CenterGeneral guidance · Listed in reference bibliography.
- CDCGeneral guidance · Listed in reference bibliography.
- NCBI BookshelfFurther reading · Listed in reference bibliography.
- Geref 50 Summary of Product Characteristics - Official diagnostic product instructions for a 50 mcg vial, at least 5 mL supplied saline, and one fasting morning 1 mcg/kg IV dose.Further reading · Listed in reference bibliography.
Reported schedule reference: PeptideDosages.com. Research findings are summarized independently from the listed sources.